CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Net sales	$ 618,700	$ 1,395,200
Cost of sales	(238,150)	(195,287)
Royalty Expense	(521,004)	(544,065)
Gross profit (loss)	(140,454)	655,848
Selling, general and administrative expenses	738,479	1,072,148
Non-cash compensation expense	19,897	98,759
Total operating expenses	758,376	1,170,907
Loss from operations	(898,830)	(515,059)
Interest expense	(255,661)	(271,790)
Gain on sale/leaseback		20,268
Other income		28,500
Loss on derivative valuation	(133,605)	(7,871,711)
Total other expense, net	(389,266)	(8,094,733)
Net loss	(1,288,096)	(8,609,792)
Net loss attributable to noncontrolling interest	153,970	575,836
Net loss attributable to CirTran	$ (1,134,126)	$ (8,033,956)
Basic and diluted loss per common share		$ (0.01)
Basic and diluted weighted-average common shares outstanding	1,827,524,511	1,498,972,923